Trade Mark Journal No.2021/053 31 December 2021
WO0000001630031 (5,42)
Office of origin: United States of America
Date of International Registration:2 July 2021
Date of designation in the UK:
2 July 2021

International priority date claimed: 4 January 2021
(United States of America)
(90447021)
- Class 5
- Pharmaceutical preparations for the prevention of cancer and immune diseases.
- Class 42
- Research and development in the field of pharmaceutical preparations for the prevention of cancer and immune diseases.
Sporos Bioventures LLC
Representative: Douglas R. Wolf, 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA